Safe Use Center

Medscape's Safe Use Center is designed to provide healthcare professionals with a valuable resource for information about safe use practices. The Safe Use Center will present updated safety data, coverage of new drug approvals and labeling changes, and a variety of educational programs and resources intended to enhance informed prescribing and other essential safe use practices. To facilitate awareness of Risk Evaluation and Mitigation Strategies (REMS), a searchable lookup tool is provided, with live links to risk management programs.

• FDA's Commitment to COVID Testing 2020 presented challenges but also significant achievements, write FDA officials.
  FDA Expert Commentaries and Interviews, January 2021
• FDA Updates Regulations on Mammography Proposed amendments to mammography regulations include increased reporting to patients and providers and greater transparency about mammography facilities.
  FDA Expert Commentaries and Interviews, June 2019
• Vaping and e-Cigarettes in Kids: An Unprecedented Epidemic   We are at the start of a rise in youth use of vaping products that is unprecedented in scope and exceeds growth rates previously seen with any other products. Clinicians have to be part of the response team.
  FDA Expert Commentaries and Interviews, January 2019
• Drug Safety Warnings and Updates: April-June 2018 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the second quarter of 2018.
  FDA Expert Commentaries and Interviews, September 2018
• Recommendations to Reduce Surgical Fires and Patient Injury Dr Lila Bahadori discusses the FDA's recent safety communication reviewing the factors that contribute to surgical fires and recommending practices to reduce them.
  FDA Expert Commentaries and Interviews, May 2018
• Drug Safety Warnings and Updates: January-March 2018 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the first quarter of 2018.
  FDA Expert Commentaries and Interviews, May 2018
• Drugs With a REMS: Benefit/Risk Counseling to Patients Do you know what to do when counseling a patient on a drug with a REMS designation? Learn more with new guidance from the FDA.
  FDA Expert Commentaries and Interviews, February 2018
• Drug Safety Warnings and Updates: October-December 2017 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the fourth quarter of 2017.
  FDA Expert Commentaries and Interviews, February 2018

Need to check a drug for REMS? Click the link below to view REMS drug information.